Challenges in addressing SUD include the stigma associated with addiction, which can prevent individuals from seeking help, and the complexity of co-occurring mental health disorders. Limited access to treatment resources and inadequate insurance coverage can also hinder effective care. Furthermore, the constant emergence of new synthetic drugs poses a significant challenge for toxicologists and healthcare providers in identifying and managing novel toxicological profiles.
